Witnessing the stock’s movement on the chart, on Wednesday, Myriad Genetics, Inc (NASDAQ: MYGN) had a quiet start as it plunged -0.15% to $6.55, before settling in for the price of $6.56 at the close. Taking a more long-term approach, MYGN posted a 52-week range of $3.76-$15.47.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -95.81%. This publicly-traded company’s shares outstanding now amounts to $93.10 million, simultaneously with a float of $88.73 million. The organization now has a market capitalization sitting at $610.55 million. At the time of writing, stock’s 50-day Moving Average stood at $7.23, while the 200-day Moving Average is $6.61.
Myriad Genetics, Inc (MYGN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. Myriad Genetics, Inc’s current insider ownership accounts for 4.81%, in contrast to 97.85% institutional ownership.
Myriad Genetics, Inc (MYGN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.0 per share during the current fiscal year.
Myriad Genetics, Inc’s EPS decrease for this current 12-month fiscal period is -95.81% and is forecasted to reach 0.06 in the upcoming year.
Myriad Genetics, Inc (NASDAQ: MYGN) Trading Performance Indicators
Let’s observe the current performance indicators for Myriad Genetics, Inc (MYGN). It’s Quick Ratio in the last reported quarter now stands at 2.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.74.
In the same vein, MYGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.33, a figure that is expected to reach -0.01 in the next quarter, and analysts are predicting that it will be 0.06 at the market close of one year from today.
Technical Analysis of Myriad Genetics, Inc (MYGN)
Going through the that latest performance of [Myriad Genetics, Inc, MYGN]. Its last 5-days volume of 1.19 million was inferior to the volume of 1.56 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 16.45% While, its Average True Range was 36.03.
Raw Stochastic average of Myriad Genetics, Inc (MYGN) in the period of the previous 100 days is set at 56.96%, which indicates a major rise in contrast to 16.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.29 that was lower than 0.39 volatility it exhibited in the past 100-days period.
